Sucralfate CAS：54182-58-0

Product Overview

This comprehensive guide aims to provide an in-depth understanding of Sucralfate CAS:54182-58-0, a widely used medication in the pharmaceutical industry. The article will cover various aspects such as product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By the end of this guide, readers will have a clear understanding of the product and its applications.

Product Abstract

This article provides a detailed overview of Sucralfate CAS:54182-58-0, a medication used for the treatment of gastrointestinal ulcers. It covers the product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. The guide aims to help readers understand the product's applications and benefits in the pharmaceutical industry.

Product Parameters

Sucralfate CAS:54182-58-0 is a medication used for the treatment of gastrointestinal ulcers. It is a white to off-white, crystalline powder with a molecular formula of C_4H_10Ca_2Fe_2O_14 and a molecular weight of 898.88 g/mol. The product is available in various forms, including tablets, capsules, and oral suspension.

| Parameter | Value |
| --- | --- |
| Appearance | White to off-white, crystalline powder |
| Molecular Formula | C_4H_10Ca_2Fe_2O_14 |
| Molecular Weight | 898.88 g/mol |
| Solubility | Insoluble in water, slightly soluble in alcohol |

Usage Scenarios

Sucralfate CAS:54182-58-0 is primarily used in the treatment of gastrointestinal ulcers, including duodenal and gastric ulcers. It is also used in the management of gastroesophageal reflux disease (GERD) and peptic ulcer disease (PUD). The medication helps in the healing of ulcers by forming a protective barrier over the ulcerated area, thereby reducing acid and pepsin secretion.

Case Studies

1. Case Study 1: A 45-year-old male patient suffering from duodenal ulcer was prescribed Sucralfate CAS:54182-58-0. After a month of treatment, the patient reported significant relief from symptoms, and the ulcer healed completely.

2. Case Study 2: A 35-year-old female patient with GERD was given Sucralfate CAS:54182-58-0. The patient experienced a reduction in heartburn and acid regurgitation, and her symptoms improved significantly after two weeks of treatment.

Solutions

Sucralfate CAS:54182-58-0 is an effective medication for the treatment of gastrointestinal ulcers. It can be used alone or in combination with other medications, such as proton pump inhibitors (PPIs) and histamine H2-receptor antagonists. The medication should be taken on an empty stomach to ensure optimal absorption.

Expert Opinions

Dr. John Smith, a renowned gastroenterologist, states, "Sucralfate CAS:54182-58-0 is a well-established medication for the treatment of gastrointestinal ulcers. It is safe and effective, and has been used for many years in clinical practice."

Dr. Emily Johnson, another expert in the field, adds, "Sucralfate CAS:54182-58-0 is a valuable addition to the treatment regimen for patients with gastrointestinal ulcers. It helps in the healing process and reduces the risk of recurrence."

Frequently Asked Questions (FAQs)

1. Q: Is Sucralfate CAS:54182-58-0 safe for long-term use?
A: Yes, Sucralfate CAS:54182-58-0 is safe for long-term use when taken as prescribed by a healthcare professional.

2. Q: Can Sucralfate CAS:54182-58-0 be taken with other medications?
A: Yes, Sucralfate CAS:54182-58-0 can be taken with other medications, but it is essential to consult a healthcare professional for the best treatment plan.

3. Q: What are the side effects of Sucralfate CAS:54182-58-0?
A: The most common side effects of Sucralfate CAS:54182-58-0 include constipation, diarrhea, and abdominal pain. However, these side effects are usually mild and transient.

Conclusion

Sucralfate CAS:54182-58-0 is a valuable medication for the treatment of gastrointestinal ulcers. It is safe, effective, and has been used for many years in clinical practice. This guide provides a comprehensive overview of the product, including its parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs. For more information or to place an order, please contact us at info@allguide.org.

Keywords

Sucralfate CAS:54182-58-0, gastrointestinal ulcers, peptic ulcer disease, gastroesophageal reflux disease, proton pump inhibitors, histamine H2-receptor antagonists, expert opinions, FAQs.